10 Stocks That Tanked: Why Larry Robbins’ Top Picks Are Struggling in 2026
In this article, we discuss 10 Stocks That Tanked: Why Larry Robbins’ Top Picks Are Struggling in 2026.
Myriad Genetics Inc (MYGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Squarepoint Ops LLC Maxime Fortin (Cio) | 58,568 | $252,428 | -85% | 0% |
| 2. | Winton Capital Management David Harding | 29,335 | $126,434 | 0% | |
| 3. | Royce & Associates Chuck Royce | 21,904 | $94,406 | +87% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.69 | 7,500 | $27,637.50 | 97,441 | 2026-05-14 | Filing | |
| $5.00 | 40,000 | $199,844.00 | 493,104 | 2026-03-09 | Filing | |
| $4.66 | 48,000 | $223,728.00 | 281,951 | 2026-02-27 | Filing | |
| $4.80 | 50,407 | $242,104.82 | 233,951 | 2026-02-26 | Filing | |
| $4.74 | 6,100 | $28,889.60 | 183,544 | 2026-02-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.46 | 15,000 | $66,843.00 | 171,889 | 2026-06-08 | Filing | |
| $22.93 | 15,000 | $343,950.00 | 962,378 | 2024-10-11 | Filing | |
| $26.72 | 15,000 | $400,800.00 | 977,378 | 2024-09-11 | Filing | |
| $26.17 | 2,100 | $54,961.20 | 108,013 | 2024-09-11 | Filing | |
| $27.05 | 10,000 | $270,520.00 | 121,648 | 2024-09-09 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,499,354 | $10,772,216 | 0.01% | |
| 2. | 1,721,609 | $7,422,875 | 0% | |
| 3. | 1,708,805 | $7,364,950 | 0.01% | |
| 4. | 1,499,793 | $6,464,108 | 0% | |
| 5. | 958,502 | $4,131,144 | 0% |
News See All
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2026 Earnings Call Transcript
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2026 Earnings Call Transcript May 5, 2026Myriad Genetics, Inc. misses on earnings expectations. Reported EPS is $-0.09 EPS, expectations were $-0.06.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2025 Earnings Call Transcript
Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2025 Earnings Call Transcript February 23, 2026Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.02.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2025 Earnings Call Transcript
Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2025 Earnings Call Transcript November 3, 2025 Operator: Good day, and thank you for standing by.
TD Cowen Maintained a Hold Rating on Myriad Genetics (MYGN)
Myriad Genetics, Inc. (NASDAQ:MYGN) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 5, Daniel Brennan from TD Cowen maintained a Hold rating on Myriad Genetics, Inc.
10 Best 52-Week Low Penny Stocks to Buy Now
In this article, we will look at the 10 Best 52-Week Low Penny Stocks to Buy Now. On March 26, Gabelli released its Small Cap Outlook for 2025 and beyond.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2025 Earnings Call Transcript
Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good day, and thank you for standing by.
Billionaire Larry Robbins' 10 Stock Picks with Huge Upside Potential
Larry Robbins is an American hedge fund manager and philanthropist who founded Glenview Capital Management in 2000. The firm manages capital for investors across a range of private investment funds.
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2025 Earnings Call Transcript
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2025 Earnings Call Transcript May 6, 2025Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.05.
Hedge Fund Resource Center